NASDAQ:CDNA CareDx (CDNA) Stock Forecast, Price & News $7.96 -0.01 (-0.13%) (As of 02:19 PM ET) Add Compare Share Share Today's Range$7.76▼$8.1750-Day Range$7.61▼$9.4652-Week Range$6.22▼$27.35Volume204,815 shsAverage Volume1.17 million shsMarket Capitalization$428.17 millionP/E RatioN/ADividend YieldN/APrice Target$16.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability CareDx MarketRank™ ForecastAnalyst RatingHold2.20 Rating ScoreUpside/Downside102.5% Upside$16.00 Price TargetShort InterestBearish11.97% of Float Sold ShortDividend StrengthN/ASustainability-0.66Upright™ Environmental ScoreNews Sentiment1.02Based on 5 Articles This WeekInsider TradingSelling Shares$92,877 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.73) to ($1.41) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.18 out of 5 starsMedical Sector319th out of 1,006 stocksMedical Laboratories Industry8th out of 24 stocks 4.1 Analyst's Opinion Consensus RatingCareDx has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 1 buy rating, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $16.00, CareDx has a forecasted upside of 102.5% from its current price of $7.90.Amount of Analyst CoverageCareDx has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 1.0 Short Interest Percentage of Shares Shorted11.97% of the float of CareDx has been sold short.Short Interest Ratio / Days to CoverCareDx has a short interest ratio ("days to cover") of 4.5.Change versus previous monthShort interest in CareDx has recently increased by 19.23%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldCareDx does not currently pay a dividend.Dividend GrowthCareDx does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreCareDx has received a 61.52% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "DNA sequencers", "Genomics analysis tools", and "Patient flow management systems" products. See details.Environmental SustainabilityThe Environmental Impact score for CareDx is -0.66. Previous Next 2.2 News and Social Media Coverage News SentimentCareDx has a news sentiment score of 1.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for CareDx this week, compared to 6 articles on an average week.Search InterestOnly 1 people have searched for CDNA on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added CareDx to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CareDx insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $92,877.00 in company stock.Percentage Held by InsidersOnly 5.00% of the stock of CareDx is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for CareDx are expected to grow in the coming year, from ($1.73) to ($1.41) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CareDx is -5.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CareDx is -5.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCareDx has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About CareDx (NASDAQ:CDNA) StockCareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.Read More Receive CDNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CareDx and its competitors with MarketBeat's FREE daily newsletter. Email Address CDNA Stock News HeadlinesMay 21, 2023 | americanbankingnews.comCareDx (NASDAQ:CDNA) Coverage Initiated by Analysts at StockNews.comMay 19, 2023 | americanbankingnews.comCareDx, Inc (NASDAQ:CDNA) Given Average Recommendation of "Hold" by AnalystsMay 31, 2023 | Edge On The Street (Ad)The Ignored EV Story Few Investors Know AboutLithium may grab all the headlines, but the average electric vehicle requires 146 pounds of the mineral graphite. With no producing graphite mines in North America, the U.S. government is desperate for more domestic sources of the metal to feed the EV battery supply chain.May 16, 2023 | finance.yahoo.comWhat Does The Future Hold For CareDx, Inc (NASDAQ:CDNA)? These Analysts Have Been Cutting Their EstimatesMay 16, 2023 | finance.yahoo.comShould You Exit CareDx (CDNA)?May 16, 2023 | finance.yahoo.comCareDx Showcases Digital Health Portfolio at 31st Annual UNOS Transplant Management ForumMay 12, 2023 | americanbankingnews.comCareDx (NASDAQ:CDNA) Lowered to "Neutral" at BTIG ResearchMay 12, 2023 | marketwatch.com8-K: CareDx, Inc.May 31, 2023 | Edge On The Street (Ad)146 Pounds of Graphite Needed for Each EVGraphite - not lithium - is the largest component of lithium-ion batteries used in electric vehicles. That's why 97 more graphite mines will be needed by 2035 just to keep up with battery demand for the $7 trillion EV market.May 12, 2023 | msn.comBTIG Downgrades Caredx (CDNA)May 12, 2023 | msn.comCareDx Plummets on Disappointing Q1 ShowingMay 11, 2023 | markets.businessinsider.comCareDx (CDNA) Receives a Hold from H.C. WainwrightMay 10, 2023 | msn.comA Preview Of CareDx's EarningsMay 10, 2023 | finance.yahoo.comCareDx Reports First Quarter 2023 ResultsMay 10, 2023 | finance.yahoo.comCareDx (CDNA) Reports Q1 Loss, Lags Revenue EstimatesMay 8, 2023 | finance.yahoo.comCareDx to Report First Quarter 2023 Financial ResultsMay 6, 2023 | americanbankingnews.comCareDx, Inc (NASDAQ:CDNA) Insider Sells $22,890.28 in StockApril 25, 2023 | finance.yahoo.comCareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility ConferenceApril 22, 2023 | americanbankingnews.comCareDx, Inc (NASDAQ:CDNA) Receives $16.00 Average Target Price from AnalystsApril 19, 2023 | finance.yahoo.comCareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung TransplantationApril 18, 2023 | finance.yahoo.comCareDx, Inc's (NASDAQ:CDNA) Shares Lagging The Industry But So Is The BusinessApril 15, 2023 | americanbankingnews.comCareDx (NASDAQ:CDNA) Stock Price Up 8.9%April 6, 2023 | finance.yahoo.comNational Kidney Foundation Honors CareDx with Corporate Citizenship Award for its Commitment to the Transplant CommunityApril 5, 2023 | americanbankingnews.comReginald Seeto Sells 2,818 Shares of CareDx, Inc (NASDAQ:CDNA) StockMarch 28, 2023 | americanbankingnews.comCareDx, Inc (NASDAQ:CDNA) Receives $16.00 Consensus PT from BrokeragesMarch 23, 2023 | finance.yahoo.comCareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant AssociationMarch 11, 2023 | finance.yahoo.comCareDx, Inc (NASDAQ:CDNA) Q4 2022 Earnings Call TranscriptSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CDNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CareDx and its competitors with MarketBeat's FREE daily newsletter. Email Address CDNA Company Calendar Last Earnings10/28/2021Today5/31/2023Next Earnings (Estimated)8/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medical laboratories Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CDNA CUSIPN/A CIK1217234 Webwww.caredxinc.com Phone(415) 287-2300Fax415-287-2450Employees633Year FoundedN/APrice Target and Rating Average Stock Price Forecast$16.00 High Stock Price Forecast$25.00 Low Stock Price Forecast$9.00 Forecasted Upside/Downside+100.8%Consensus RatingHold Rating Score (0-4)2.20 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.51) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-76,610,000.00 Net Margins-25.25% Pretax Margin-25.09% Return on Equity-18.65% Return on Assets-14.97% Debt Debt-to-Equity RatioN/A Current Ratio5.17 Quick Ratio4.92 Sales & Book Value Annual Sales$321.79 million Price / Sales1.33 Cash FlowN/A Price / Cash FlowN/A Book Value$8.05 per share Price / Book0.99Miscellaneous Outstanding Shares53,790,000Free Float51,103,000Market Cap$428.71 million OptionableOptionable Beta1.04 Key ExecutivesReginald SeetoPresident, Chief Executive Officer & DirectorMarica GrskovicChief Operations OfficerAbhishek JainChief Financial & Accounting OfficerSrini SrinivasSVP-Medical Affairs & Clinical OperationsAshish KothariVice President-Medical AffairsKey CompetitorsInvitaeNYSE:NVTACelcuityNASDAQ:CELCHH&L AcquisitionNYSE:HHLACastle BiosciencesNASDAQ:CSTLEnzo BiochemNYSE:ENZView All CompetitorsInsiders & InstitutionsRoyce & Associates LPBought 332,400 shares on 5/23/2023Ownership: 0.804%Ameriprise Financial Inc.Bought 15,573 shares on 5/22/2023Ownership: 0.183%JPMorgan Chase & Co.Sold 113,031 shares on 5/18/2023Ownership: 0.426%New York State Common Retirement FundSold 6,400 shares on 5/18/2023Ownership: 0.055%Susquehanna International Group LLPSold 1,500 shares on 5/16/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions CDNA Stock - Frequently Asked Questions Should I buy or sell CareDx stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CareDx in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CDNA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDNA, but not buy additional shares or sell existing shares. View CDNA analyst ratings or view top-rated stocks. What is CareDx's stock price forecast for 2023? 5 analysts have issued 1-year price targets for CareDx's stock. Their CDNA share price forecasts range from $9.00 to $25.00. On average, they expect the company's share price to reach $16.00 in the next twelve months. This suggests a possible upside of 100.8% from the stock's current price. View analysts price targets for CDNA or view top-rated stocks among Wall Street analysts. How have CDNA shares performed in 2023? CareDx's stock was trading at $11.41 at the start of the year. Since then, CDNA stock has decreased by 30.1% and is now trading at $7.97. View the best growth stocks for 2023 here. Are investors shorting CareDx? CareDx saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 6,200,000 shares, an increase of 19.2% from the April 30th total of 5,200,000 shares. Based on an average trading volume of 1,380,000 shares, the short-interest ratio is presently 4.5 days. Currently, 12.0% of the shares of the stock are sold short. View CareDx's Short Interest. When is CareDx's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023. View our CDNA earnings forecast. How were CareDx's earnings last quarter? CareDx, Inc (NASDAQ:CDNA) announced its quarterly earnings results on Thursday, October, 28th. The company reported $0.07 earnings per share for the quarter, beating analysts' consensus estimates of ($0.14) by $0.21. The business earned $75.60 million during the quarter, compared to analysts' expectations of $74.11 million. CareDx had a negative trailing twelve-month return on equity of 18.65% and a negative net margin of 25.25%. The company's revenue was up 41.6% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.06) EPS. What ETFs hold CareDx's stock? ETFs with the largest weight of CareDx (NASDAQ:CDNA) stock in their portfolio include ARK Genomic Revolution ETF (ARKG), Jacob Forward ETF (JFWD), ROBO Global Healthcare Technology and Innovation ETF (HTEC), Global X Genomics & Biotechnology ETF (GNOM), SPDR S&P Biotech ETF (XBI), Direxion Daily S&P Biotech Bull 3X Shares (LABU), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and Principal Healthcare Innovators ETF (BTEC). What other stocks do shareholders of CareDx own? Based on aggregate information from My MarketBeat watchlists, some companies that other CareDx investors own include Block (SQ), Roku (ROKU), Exact Sciences (EXAS), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Enphase Energy (ENPH), Johnson & Johnson (JNJ), Activision Blizzard (ATVI) and Alibaba Group (BABA). What is CareDx's stock symbol? CareDx trades on the NASDAQ under the ticker symbol "CDNA." Who are CareDx's major shareholders? CareDx's stock is owned by many different institutional and retail investors. Top institutional investors include ARK Investment Management LLC (12.67%), State Street Corp (9.07%), BlackRock Inc. (8.13%), Armistice Capital LLC (5.83%), Sumitomo Mitsui Trust Holdings Inc. (5.12%) and Nikko Asset Management Americas Inc. (5.12%). Insiders that own company stock include Ankur Dhingra, George Bickerstaff, Grace Colon, Michael Brian Bell, Michael Goldberg, Paul Adler, Peter Maag, Ralph Snyderman, Reginald Seeto, Sasha King, Thomas A Thomas and William A Hagstrom. View institutional ownership trends. How do I buy shares of CareDx? Shares of CDNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is CareDx's stock price today? One share of CDNA stock can currently be purchased for approximately $7.97. How much money does CareDx make? CareDx (NASDAQ:CDNA) has a market capitalization of $428.71 million and generates $321.79 million in revenue each year. The company earns $-76,610,000.00 in net income (profit) each year or ($1.51) on an earnings per share basis. How many employees does CareDx have? The company employs 633 workers across the globe. How can I contact CareDx? CareDx's mailing address is 1 TOWER PLACE 9TH FLOOR, SOUTH SAN FRANCISCO CA, 94080. The official website for the company is www.caredxinc.com. The company can be reached via phone at (415) 287-2300, via email at caroline.corner@westwicke.com, or via fax at 415-287-2450. This page (NASDAQ:CDNA) was last updated on 5/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CareDx, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.